Advertisement
Advertisement
U.S. Markets close in 4 hrs 11 mins
Advertisement
Advertisement
Advertisement
Advertisement

Pharmagreen Biotech Inc. (PHBI)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0062-0.0007 (-10.79%)
As of 09:46AM EST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/6/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.0200
52 Week Low 30.0010
50-Day Moving Average 30.0057
200-Day Moving Average 30.0085

Share Statistics

Avg Vol (3 month) 3365.07k
Avg Vol (10 day) 3238.69k
Shares Outstanding 5454.76M
Implied Shares Outstanding 6N/A
Float 8353.11M
% Held by Insiders 117.61%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 01, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:200
Last Split Date 3Jul 01, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-688.52%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-1.6M
Diluted EPS (ttm)-0.0260
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)24.26k
Total Cash Per Share (mrq)0
Total Debt (mrq)388.25k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.10
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-389.15k
Levered Free Cash Flow (ttm)48.36k
Advertisement
Advertisement